Rigel Pharmaceuticals | RIGL - نسبة السعر إلى الأرباح





Pe تغيير تاريخ
Amgen 19.84 5.47 2026-03
Anika Therapeutics 47.54 27.2 2024-06
AstraZeneca 29.59 2.3 2026-03
BioMarin Pharmaceutical 15.28 3.96 2026-03
Bristol-Myers Squibb 9.08 0.2 2026-03
Daiichi Sankyo 20.73 1.74 2025-12
Eli Lilly 40.27 0.06 2026-03
Halozyme Therapeutics 11.35 11.8 2026-03
Intrexon 7.54 221.44 2021-12
Ionis Pharmaceuticals 396.15 79.28 2022-09
Ligand Pharmaceuticals 56.5 26.8 2026-03
Neurocrine Biosciences 28.09 807.38 2026-03
Pfizer 9.32 5.16 2026-03
Regeneron Pharmaceuticals 25.14 7.03 2026-03
Rigel Pharmaceuticals 8.61 8.4 2025-03
Veracyte 24.89 20.41 2026-03